Induction of apoptosis by paclitaxel in human oral carcinoma cells

International Journal of Oral and Maxillofacial Surgery

Volumn 35, Issue 7, 2006, Pages 649-652

  Nonaka, M ^a   Ikeda, H ^a   Fujisawa, A ^a   Uehara, M ^a   Inokuchi, T ^a  

^a Division of Oral and Maxillofacial Surgical Reconstruction and Functional Restoration ^*  (Japan)

Author keywords

apoptosis; Bax; Bcl 2; paclitaxel

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HOE 33342; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MOUTH CARCINOMA; PROTEIN EXPRESSION; TIME; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MOUTH NEOPLASMS; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33744979532     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2006.01.011     Document Type: Article

References (18)

1. Antonsson B., and Martinou J.C. The Bcl-2 protein family. Exp Cell Res 256 (2000) 50-57
2. Bacus S.S., Gudkov A.V., Lowe M., Lyass L., Yung Y., Komarov A.P., Keyomarsi K., Yarden Y., and Seger R. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20 (2001) 147-155
3. Carre M., Carles G., Andre N., Douillard S., Ciccolini J., Briand C., and Braguer D. Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis. Biochem Pharmacol 63 (2002) 1831-1842
4. Cheng S.C., Luo D., and Xie Y. Taxol induced Bcl-2 protein phosphorylation in human hepatocellular carcinoma QGY-7703 cell line. Cell Biol Int 25 (2001) 261-265
5. Cory S., Huang D.C., and Adams J.M. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22 (2003) 8590-8607
6. Debatin K.M. Cytotoxic drugs, programmed cell death, and the immune system: defining new roles in an old play. J Natl Cancer Inst 89 (1997) 750-751
7. Fan M., Du L., Stone A.A., Gilbert K.M., and Chambers T.C. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1. Cancer Res 60 (2000) 6403-6407
8. Fowler C.A., Perks C.M., Newcomb P.V., Savage P.B., Farndon J.R., and Holly J.M. Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. Int J Cancer 88 (2000) 448-453
9. Fujisawa A., Ikeda H., Tobita T., and Inokuchi T. Establishment and characterization of human oral squamous cell carcinoma cell line. Oral Med Pathol 9 (2004) 133-139
10. Green D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102 (2000) 1-4
11. Haldar S., Chintapalli J., and Croce C.M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56 (1996) 1253-1255
12. Herr I., and Debatin K.M. Cellular stress response and apoptosis in cancer therapy. Blood 98 (2001) 2603-2614
13. Huisman C., Ferreira C.G., Broker L.E., Rodriguez J.A., Smit E.F., Postmus P.E., Kruyt F.A., and Giaccone G. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Clin Cancer Res 8 (2002) 596-606
14. Kaufmann S.H., and Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256 (2000) 42-49
15. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat Med 6 (2000) 513-519
16. Meijerink J.P., Mensink E.J., Wang K., Sedlak T.W., Sloetjes A.W., Witte T., Waksman G., and Korsmeyer S.J. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 91 (1998) 2991-2997
17. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., and Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275 (1997) 967-969
18. Zhou J., Gupta K., Yao J., Ye K., Panda D., Giannakakou P., and Joshi H.C. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine. J Biol Chem 77 (2002) 39777-39785